Literature DB >> 3088563

Isolation of ras GTP-binding mutants using an in situ colony-binding assay.

L A Feig, B T Pan, T M Roberts, G M Cooper.   

Abstract

We have developed a strategy to isolate mutant ras genes encoding proteins defective in GTP binding. Random in vitro mutagenesis of a v-Harvey (Ha)-ras expression vector was followed by an in situ GTP-binding assay on lysed bacterial colonies. Single amino acid substitutions at ras codon 83, 119, or 144 decreased the affinity of p21 for GTP by a factor of 25-100 primarily as a consequence of increased rates of dissociation of GTP from p21. Nevertheless, these mutant genes induced transformation of NIH 3T3 cells with efficiencies comparable to wild-type v-Ha-ras. In transformed cells, mutant p21s were phosphorylated to a degree similar to that of wild-type v-Ha-ras p21, suggesting that a decrease in affinity by a factor of 100 did not prevent the mutant ras protein from binding GTP in vivo. These results are discussed with respect to the role of GTP in the regulation of p21 function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088563      PMCID: PMC323790          DOI: 10.1073/pnas.83.13.4607

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.

Authors:  J B Gibbs; I S Sigal; M Poe; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

2.  Analysis of the transforming potential of the human H-ras gene by random mutagenesis.

Authors:  O Fasano; T Aldrich; F Tamanoi; E Taparowsky; M Furth; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

Review 3.  Oncogenes and cancer: the p21 ras genes.

Authors:  T Y Shih; M O Weeks
Journal:  Cancer Invest       Date:  1984       Impact factor: 2.176

4.  Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity.

Authors:  V Manne; E Bekesi; H F Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins.

Authors:  J C Lacal; E Santos; V Notario; M Barbacid; S Yamazaki; H Kung; C Seamans; S McAndrew; R Crowl
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

6.  Comparative biochemical properties of normal and activated human ras p21 protein.

Authors:  J P McGrath; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

7.  The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.

Authors:  R W Sweet; S Yokoyama; T Kamata; J R Feramisco; M Rosenberg; M Gross
Journal:  Nature       Date:  1984 Sep 20-26       Impact factor: 49.962

8.  Sequence of the initiation factor IF2 gene: unusual protein features and homologies with elongation factors.

Authors:  C Sacerdot; P Dessen; J W Hershey; J A Plumbridge; M Grunberg-Manago
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  Yeast and mammalian ras proteins have conserved biochemical properties.

Authors:  G L Temeles; J B Gibbs; J S D'Alonzo; I S Sigal; E M Scolnick
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

View more
  46 in total

1.  The dynamin-like protein DLP1 is essential for normal distribution and morphology of the endoplasmic reticulum and mitochondria in mammalian cells.

Authors:  K R Pitts; Y Yoon; E W Krueger; M A McNiven
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

2.  The Ras mutant D119N is both dominant negative and activated.

Authors:  R H Cool; G Schmidt; C U Lenzen; H Prinz; D Vogt; A Wittinghofer
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  A Rab2 mutant with impaired GTPase activity stimulates vesicle formation from pre-Golgi intermediates.

Authors:  E J Tisdale
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

4.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

5.  rasH mutants deficient in GTP binding.

Authors:  C J Der; B T Pan; G M Cooper
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

6.  G alpha 12 and G alpha 13 subunits define a fourth class of G protein alpha subunits.

Authors:  M P Strathmann; M I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 7.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

8.  GTP-binding domain: three consensus sequence elements with distinct spacing.

Authors:  T E Dever; M J Glynias; W C Merrick
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

9.  Expression of the Aplysia californica rho gene in Escherichia coli: purification and characterization of its encoded p21 product.

Authors:  P S Anderson; J C Lacal
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

10.  Two types of RAS mutants that dominantly interfere with activators of RAS.

Authors:  V Jung; W Wei; R Ballester; J Camonis; S Mi; L Van Aelst; M Wigler; D Broek
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.